Ovid Therapeutics Inc.

NASDAQ: OVID · Real-Time Price · USD
0.96
0.12 (14.24%)
At close: Aug 15, 2025, 3:59 PM
0.97
0.54%
After-hours: Aug 15, 2025, 07:58 PM EDT

Ovid Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
566K 391.69K 1.5M 208.38M
Cost of Revenue
n/a n/a 1.38M n/a
Gross Profit
566K 392K 1.5M 208.38M
Operating Income
-61.88M -59.28M -55.55M 124.21M
Interest Income
3.9M 4.9M n/a n/a
Pretax Income
-26.43M -52.34M -54.17M 124.16M
Net Income
-26.43M -52.34M -54.17M 122.83M
Selling & General & Admin
25.68M 31.09M 32.43M 37.23M
Research & Development
36.77M 28.59M 24.62M 46.94M
Other Expenses
1K n/a n/a n/a
Operating Expenses
62.45M 59.67M 57.05M 84.17M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
62.45M 59.67M 57.05M 84.17M
Income Tax Expense
n/a n/a n/a 1.33M
Shares Outstanding (Basic)
70.91M 70.58M 70.42M 67.48M
Shares Outstanding (Diluted)
70.91M 70.58M 70.42M 68.07M
EPS (Basic)
-0.37 -0.74 -0.77 1.78
EPS (Diluted)
-0.37 -0.74 -0.77 1.76
EBITDA
-57.77M -57.01M -54.17M 124.4M
EBIT
-58.38M -57.58M -55.55M 124.16M
Depreciation & Amortization
613K 568K 1.38M 237K